MYCN and neuroblastoma: In neuroblastoma (n = 148), MYCN non-amplified neuroblastoma cases were enriched in Myeloid Predominant (n = 41, p = 0.007), while neuroblastoma MYCN amplified showed a trend toward Immune Desert (n = 16, p = 0.1) [90, 91].